Literature DB >> 4056801

Restrictive transport of a lipid-soluble peptide (cyclosporin) through the blood-brain barrier.

W T Cefalu, W M Pardridge.   

Abstract

The blood-brain barrier (BBB) transport of a highly lipid-soluble peptide, [3H]cyclosporin, was studied in ketamine-anesthetized rats using the carotid artery injection technique. For comparison, peptide transport into rat liver was also assessed with the portal vein injection technique. Despite the high lipid solubility of this peptide (1-octanol/Ringer's partition coefficient = 991 +/- 55), the extraction by rat brain was only 2.9 +/- 0.5% in the presence of 80% human serum, and this value approximated the extraction for a poorly diffusible substance such as [3H]inulin, 2.0 +/- 0.1%. In contrast, the hepatic extraction of [3H]cyclosporin was high, 84 +/- 2%, in the presence of 80% human serum. The BBB transport of cyclosporin is markedly restricted owing to the combined effects of binding by serum proteins and a paradoxically low permeability of the BBB to the peptide.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4056801     DOI: 10.1111/j.1471-4159.1985.tb10557.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  12 in total

1.  High-fat meals increase the clearance of cyclosporine.

Authors:  S K Gupta; L Z Benet
Journal:  Pharm Res       Date:  1990-01       Impact factor: 4.200

2.  Inhibition of P-glycoprotein: rapid assessment of its implication in blood-brain barrier integrity and drug transport to the brain by an in vitro model of the blood-brain barrier.

Authors:  L Fenart; V Buée-Scherrer; L Descamps; C Duhem; M G Poullain; R Cecchelli; M P Dehouck
Journal:  Pharm Res       Date:  1998-07       Impact factor: 4.200

3.  The effect of conformation on membrane permeability of an acyloxyalkoxy-linked cyclic prodrug of a model hexapeptide.

Authors:  S Gangwar; S D Jois; T J Siahaan; D G Vander Velde; V J Stella; R T Borchardt
Journal:  Pharm Res       Date:  1996-11       Impact factor: 4.200

Review 4.  Brain microvascular P-glycoprotein and a revised model of multidrug resistance in brain.

Authors:  P L Golden; W M Pardridge
Journal:  Cell Mol Neurobiol       Date:  2000-04       Impact factor: 5.046

Review 5.  Distribution of cyclosporin in organ transplant recipients.

Authors:  Fatemeh Akhlaghi; Andrew K Trull
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

6.  The absorption site of cyclosporin in the human gastrointestinal tract.

Authors:  J Drewe; C Beglinger; T Kissel
Journal:  Br J Clin Pharmacol       Date:  1992-01       Impact factor: 4.335

7.  P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs.

Authors:  A H Schinkel; E Wagenaar; C A Mol; L van Deemter
Journal:  J Clin Invest       Date:  1996-06-01       Impact factor: 14.808

8.  Brain uptake and anticancer activities of vincristine and vinblastine are restricted by their low cerebrovascular permeability and binding to plasma constituents in rat.

Authors:  N H Greig; T T Soncrant; H U Shetty; S Momma; Q R Smith; S I Rapoport
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

Review 9.  Learned immunosuppression: extinction, renewal, and the challenge of reconsolidation.

Authors:  Martin Hadamitzky; Harald Engler; Manfred Schedlowski
Journal:  J Neuroimmune Pharmacol       Date:  2012-07-13       Impact factor: 4.147

Review 10.  Cyclosporin clinical pharmacokinetics.

Authors:  A Fahr
Journal:  Clin Pharmacokinet       Date:  1993-06       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.